TrialAnti-cancer drugs2018

Palbociclib has no clinically relevant effect on the QTc interval in patients with advanced breast cancer.

Chandrasekar Durairaj et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.